BPC-157 vs Pentosan Polysulfate
A side-by-side research comparison of BPC-157 and Pentosan Polysulfate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | BPC-157 | Pentosan Polysulfate |
|---|---|---|
| Full name | Body Protection Compound-157 | Pentosan Polysulfate Sodium |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | FDA Approved |
| Mechanism | Upregulates growth factor expression including VEGF and promotes angiogenesis, modulates nitric oxide system, and interacts with the dopaminergic system. | Acts as a glycosaminoglycan analog that coats bladder mucosa, inhibits complement activation, and stimulates proteoglycan synthesis in cartilage. |
| Molecular weight | 1419.53 Da | 4000-6000 Da (average) |
| Half-life | ~4 hours | ~24 hours |
| Bioavailability | Variable; oral and injectable forms available | ~3-6% oral; higher via injection |
| Typical dose | 250-500 mcg per dose | 100 mg |
| Frequency | 1-2x daily | 3x daily (oral) |
| Route | Subcutaneous injection (or oral capsules) | Oral or subcutaneous injection |
BPC-157 reported benefits
- Accelerated tendon and ligament healing
- Gut lining protection and repair
- Neuroprotective effects
- Anti-inflammatory properties
- Muscle tear recovery
Pentosan Polysulfate reported benefits
- Bladder wall protection
- Cartilage repair support
- Anti-inflammatory action
- Joint pain reduction
Related comparisons
Research and educational reference only. Not medical advice.